P. Oehr

998 total citations
51 papers, 669 citations indexed

About

P. Oehr is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P. Oehr has authored 51 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P. Oehr's work include Medical Imaging Techniques and Applications (13 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Urinary and Genital Oncology Studies (8 papers). P. Oehr is often cited by papers focused on Medical Imaging Techniques and Applications (13 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Urinary and Genital Oncology Studies (8 papers). P. Oehr collaborates with scholars based in Germany, Denmark and Egypt. P. Oehr's co-authors include Kirsten Bouchelouche, Klaus Willecke, Gerard J. van Kamp, Peter Kenemans, Rob A. Verstraeten, D. Krebs, A. Bockisch, Uwe Wagner, G. Stöcklin and H.-J. Biersack and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Urology and Clinical Chemistry.

In The Last Decade

P. Oehr

45 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Oehr Germany 14 286 194 139 110 101 51 669
Kazushige Tsutsui Japan 14 92 0.3× 260 1.3× 118 0.8× 186 1.7× 214 2.1× 31 858
Joan Gretton United States 9 325 1.1× 289 1.5× 285 2.1× 70 0.6× 149 1.5× 11 825
June‐Key Chung South Korea 24 704 2.5× 312 1.6× 235 1.7× 328 3.0× 173 1.7× 58 1.4k
Gang Ren China 20 474 1.7× 251 1.3× 288 2.1× 270 2.5× 159 1.6× 62 1.0k
Hirofumi Kishi Japan 12 332 1.2× 419 2.2× 302 2.2× 157 1.4× 177 1.8× 19 928
M. Van Eijkeren Belgium 18 338 1.2× 305 1.6× 248 1.8× 267 2.4× 112 1.1× 35 855
Ilaria Grassi Italy 12 330 1.2× 146 0.8× 116 0.8× 276 2.5× 38 0.4× 25 851
A Harłozińska Poland 14 103 0.4× 67 0.3× 234 1.7× 219 2.0× 83 0.8× 55 587
P.W. Doherty United States 7 501 1.8× 99 0.5× 134 1.0× 128 1.2× 60 0.6× 9 671
Mélanie Briand France 16 83 0.3× 87 0.4× 274 2.0× 139 1.3× 57 0.6× 35 648

Countries citing papers authored by P. Oehr

Since Specialization
Citations

This map shows the geographic impact of P. Oehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Oehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Oehr more than expected).

Fields of papers citing papers by P. Oehr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Oehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Oehr. The network helps show where P. Oehr may publish in the future.

Co-authorship network of co-authors of P. Oehr

This figure shows the co-authorship network connecting the top 25 collaborators of P. Oehr. A scholar is included among the top collaborators of P. Oehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Oehr. P. Oehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Oehr, P., et al.. (2010). Usefulness of combined FDG-PET with CT or tumour markers in lung cancer diagnosis.. PubMed. 30(5). 1741–5. 2 indexed citations
3.
Bouchelouche, Kirsten, Jacek Capala, & P. Oehr. (2009). Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer. Current Opinion in Oncology. 21(5). 469–474. 23 indexed citations
4.
Bouchelouche, Kirsten & P. Oehr. (2008). Recent developments in urologic oncology: positron emission tomography molecular imaging. Current Opinion in Oncology. 20(3). 321–326. 38 indexed citations
5.
Oehr, P. & Kirsten Bouchelouche. (2007). Imaging of prostate cancer. Current Opinion in Oncology. 19(3). 259–264. 29 indexed citations
6.
Oehr, P.. (2005). Proteomics-derived Biomarkers for Early Detection of Bladder Cancer. European Oncology & Haematology. 1–1. 1 indexed citations
7.
Ruhlmann, J., P. Oehr, & H. J. Biersack. (1999). PET in oncology : basics and clinical application. Springer eBooks. 7 indexed citations
8.
Oehr, P., et al.. (1999). [Inhibition of 18F-FDG uptake in glioblastoma cells by FDG and glucose].. PubMed. 26(3). 101–3. 1 indexed citations
9.
Schomburg, A., et al.. (1997). Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice. Diseases of the Colon & Rectum. 40(10). 1195–1204. 47 indexed citations
10.
11.
Ota, Yoriko, P. Oehr, Noriyuki Inaba, & H Takamizawa. (1993). The Application of Immunotargeting into Cancer Chemotherapy with Carboplatin:in vitroandin vivoStudies. Asia-Oceania Journal of Obstetrics and Gynaecology. 19(4). 449–457.
12.
Biersack, H.-J., et al.. (1992). The role of nuclear medicine in oncology. Annals of Nuclear Medicine. 6(3). 131–136. 13 indexed citations
13.
Bockisch, Andreas, et al.. (1989). Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer. Archives of Gynecology and Obstetrics. 244(4). 193–206. 8 indexed citations
14.
Oehr, P., et al.. (1984). Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancer. Urological Research. 12(2). 125–8. 26 indexed citations
15.
Oehr, P., et al.. (1984). Distribution, sensitivity, and specificity of CEA, TPA, and (CEA x TPA) marker product values in patients with carcinoma of the bladder. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations
16.
Oehr, P., et al.. (1982). [Importance of serum and urine CEA determinations in the diagnosis of bladder cancer].. PubMed. 49(3-4). 307–11. 1 indexed citations
17.
18.
Oehr, P., et al.. (1980). Bedeutung von biologischen Markersubstanzen für die Diagnose des Harnblasenkarzinoms. Oncology Research and Treatment. 3(5). 238–246. 1 indexed citations
19.
20.
Nakano, Hiroyasu, et al.. (1976). [Active enhancement of canine kidney allografts (author's transl)].. PubMed. 151(3). 250–3.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazushige Tsutsui Breakdown of academic impact, for papers by Joan Gretton Breakdown of academic impact, for papers by June‐Key Chung Breakdown of academic impact, for papers by Gang Ren Breakdown of academic impact, for papers by Hirofumi Kishi Breakdown of academic impact, for papers by M. Van Eijkeren Breakdown of academic impact, for papers by Ilaria Grassi Breakdown of academic impact, for papers by A Harłozińska Breakdown of academic impact, for papers by P.W. Doherty Breakdown of academic impact, for papers by Mélanie Briand
Rankless by CCL
2026